Table 3.
Evaluation | Raw scores at each evaluation | Adjusted estimated mean changes | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 1 to 2 | 2 to 3 | 3 to 4 | 1 to 3 | 2 to 4 | 1 to 4 | Each eval to the next | ||
Expected no. of sessions | Initial | 20 | 40 | 60 | ||||||||
Ped NRS | ||||||||||||
Upper extremity (n=15) | Mean (SD) | 46 (19) | 51 (22) | 52 (21) | 52 (22) | 5.5* | 1.0 | 0.1 | 6.5* | 1.1 | 6.5* | 2.1* |
Median (Q1-Q3) | 53 (33–60) | 60 (34–70) | 60 (40–69) | 60 (36–72) | ||||||||
Range, min–max | 7–70 | 8–72 | 9–72 | 9–72 | ||||||||
Trunk (n=23) | Mean (SD) | 19 (8) | 20 (8) | 22 (8) | 23 (7) | 1.8* | 1.1 | 1.3* | 2.9* | 2.4* | 4.2* | 1.4* |
Median (Q1-Q3) | 18 (14–23) | 20 (17–23) | 21 (17–26) | 22 (20–26) | ||||||||
Range, min–max | 4 to 35 | 6 to 36 | 8 to 36 | 10 to 36 | ||||||||
Lower extremity (n=23) | Mean (SD) | 10 (6) | 11 (7) | 13 (8) | 13 (8) | 1.3 | 1.1 | 0.7 | 2.3* | 1.7* | 3.0* | 1.0* |
Median (Q1-Q3) | 8 (7–12) | 8 (7–13) | 10 (8–14) | 10 (8–15) | ||||||||
Range, min–max | 5 to 34 | 6 to 36 | 6 to 37 | 6 to 37 | ||||||||
Total (n=23) | Mean (SD) | 84 (27) | 90 (27) | 94 (28) | 95 (28) | 6.6* | 3.1* | 1.7 | 9.7* | 4.8* | 11.4* | 3.7* |
Median (Q1-Q3) | 92 (75–104) | 98 (86–107) | 100 (88–113) | 100 (89–111) | ||||||||
Range, min–max | 16 to 115 | 21 to 128 | 24 to 140 | 27 to 145 | ||||||||
SATCo (n=24) | Mean (SD) | 8 (5) | 11 (4) | 12 (4) | 13 (3) | 2.6* | 1.6* | 0.9 | 4.3* | 2.5* | 5.2* | 1.7* |
Median (Q1-Q3) | 8 (5–11) | 10 (8–13) | 11 (10–16) | 13 (11–15) | ||||||||
Range, min–max | 0–19 | 2–20 | 6–20 | 8–20 |
* Significant, p < .05.